Structure-guided secretome analysis of gall-forming microbes offers insights into effector diversity and evolution

  1. Départment de Phytologie, Faculté des sciences de l’agriculture et de l’alimentation, Université Laval, Quebec City, Canada
  2. Centre de recherche et d’innovation sur les végétaux (CRIV), Université Laval, Quebec City, Canada
  3. L’Institute EDS, Université Laval, Quebec City, Canada

Peer review process

Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, public reviews, and a provisional response from the authors.

Read more about eLife’s peer review process.

Editors

  • Reviewing Editor
    Kenichi Tsuda
    Huazhong Agricultural University, Wuhan, China
  • Senior Editor
    Detlef Weigel
    Max Planck Institute for Biology Tübingen, Tübingen, Germany

Reviewer #1 (Public review):

Summary:

This manuscript presents a comprehensive structure-guided secretome analysis of gall-forming microbes, providing valuable insights into effector diversity and evolution. The authors have employed AlphaFold2 to predict the 3D structures of the secretome from selected pathogens and conducted a thorough comparative analysis to elucidate commonalities and unique features of effectors among these phytopathogens.

Strengths:

The discovery of conserved motifs such as 'CCG' and 'RAYH' and their central role in maintaining the overall fold is an insightful finding. Additionally, the discovery of a nucleoside hydrolase-like fold conserved among various gall-forming microbes is interesting.

Weaknesses:

Important conclusions are not verified by experiments.

Reviewer #2 (Public review):

Summary:

Soham Mukhopadhyay et al. investigated the protein folding of the secretome from gall-forming microbes using the AI-based structure modeling tool AlphaFold2. Their study analyzed six gall-forming species, including two Plasmodiophorid species and four others spanning different kingdoms, along with one non-gall-forming Plasmodiophorid species, Polymyxa betae. The authors found no effector fold specifically conserved among gall-forming pathogens, leading to the conclusion that their virulence strategies are likely achieved through diverse mechanisms. However, they identified an expansion of the Ankyrin repeat family in two gall-forming Plasmodiophorid species, with a less pronounced presence in the non-gall-forming Polymyxa betae. Additionally, the study revealed that known effectors such as CCG and AvrSen1 belong to sequence-unrelated but structurally similar (SUSS) effector clusters.

Strengths:

(1) The bioinformatics analyses presented in this study are robust, and the AlphaFold2-derived resources deposited in Zenodo provide valuable resources for researchers studying plant-microbe interactions. The manuscript is also logically organized and easy to follow.

(2) The inclusion of the non-gall-forming Polymyxa betae strengthens the conclusion that no effector fold is specifically conserved in gall-forming pathogens and highlights the specific expansion of the Ankyrin repeat family in gall-forming Plasmodiophorids.

(3) Figure 4a and 4b effectively illustrate the SUSS effector clusters, providing a clear visual representation of this finding.

(4) Figure 1 is a well-designed, comprehensive summary of the number and functional annotations of putative secretomes in gall-forming pathogens. Notably, it reveals that more than half of the analyzed effectors lack known protein domains in some pathogens, yet some were annotated based on their predicted structures, despite the absence of domain annotations.

Weaknesses:

(1) The effector families discussed in this paper remain hypothetical in terms of their functional roles, which is understandable given the challenges of demonstrating their functions experimentally. However, this highlights the need for experimental validation as a next step.

(2) Some analyses, such as those in Figure 4e, emphasize motifs derived from sequence alignments of SUSS effector clusters. Since these effectors are sequence-unrelated, sequence alignments might be unreliable. It would be more rigorous to perform structure-based alignments in addition to sequence-based ones for motif confirmation. For instance, methods described in Figure 3E of de Guillen et al. (2015, https://doi.org/10.1371/journal.ppat.1005228) or tools like Foldseek (https://search.foldseek.com/foldmason) could be useful for aligning structures of multiple sequences.

(3) When presenting AlphaFold-generated structures, it is essential to include confidence scores such as pLDDT and PAE. For example, in Figure 1D of Derbyshire and Raffaele (2023, https://doi.org/10.1038/s41467-023-40949-9), the structural representations were colored red due to their high pLDDT scores, emphasizing their reliability.

Author response:

We appreciate the constructive feedback provided by the reviewers and the editorial board. We are delighted by the positive reception of our work and the thoughtful insights shared.

Regarding the validation of our predicted interactions, we are currently conducting yeast two-hybrid (Y2H) assays using a commercially available Arabidopsis thaliana cDNA library to screen for interacting partners of the ANK putative effector PBTT_00818 from Plasmodiophora brassicae. Following this initial screening, we will validate positive interactions through targeted 1-to-1 Y2H assays. In particular, we aim to confirm the AlphaFold Multimer-predicted interaction between PBTT_00818 and MPK3, a key immunity-related kinase in Arabidopsis.

We are grateful for the reviewers’ thoughtful suggestions regarding clustering visualization, sequence vs. structure-based motif alignments, and structural confidence assessments. We will carefully incorporate these improvements in our planned revisions.

Once again, we thank the editors and reviewers for their rigorous and constructive assessment. We look forward to implementing these refinements and submitting an updated version that further enhances the impact of our study.

  1. Howard Hughes Medical Institute
  2. Wellcome Trust
  3. Max-Planck-Gesellschaft
  4. Knut and Alice Wallenberg Foundation